, Alzheimer Annexe n°7 : Test de l'évaluation in vitro de l'activité inhibitrice de MT5-MMP et MT1-MMP des composés synthétisés au CERMN Annexe n°8 : Les Zinc Binding Groups (ZBG) les plus fréquemment retrouvés Annexe n°9 : Choix d'une conformation de MT5-MMP et MT1-MMP Annexe n°10 : Poster Annexe n°1 : Nomenclature des Enzymes Document issu de l' « ENZYME nomenclature database, Rôles des MMP dans les maladies neurodégénératives Annexe n°4 : Mini Mental State Examination Annexe n°5 : Voies de signalisation liées à la Maladie d, vol.3

S. ). Genève, *. Consultable-sur-le-serveur-expasy, and . Sur,

, Rôles des MMP dans les maladies neurodégénératives Document issu de la publication de Brkic et Al. 2015 « Friends or Foes Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases, vol.3

M. Khrestchatisky, J. Jourquin, C. Ogier, G. Charton, and A. Bernard, Les Métalloprotéases de la matrice et leurs inhibiteurs , des modulateurs des interactions neuro-immunes et des processus physiopathologiques dans le système nerveux, vol.197, pp.133-144, 2003.

Y. Christiane, V. Emonard, and H. Emonard, Implication des métalloprotéases matricielles en obstétrique: De la nidation a l'accouchement, Rev. Med. Liege, vol.69, pp.46-50, 2014.

J. Gross and C. M. Lapiere, Collagenolytic Activity in Amphibian Tissues: a Tissue Culture Assay. Proc. Natl. Acad. Sci, vol.48, pp.1014-1022, 1962.

E. Bauer, J. Gordon, M. Reddick, and A. Eisen, Quantitation and Immunocytochemichal Localization of Human Skin Collagenase in Basal Cell Carcinoma, J. Invest. Dermatol, vol.69, pp.363-367, 1977.

P. Artimo, ExPASy: SIB bioinformatics resource portal, Nucleic Acids Res, vol.40, pp.597-603, 2012.

H. Nagase, J. F. Woessner, and . Metalloproteinases, J. Biol. Chem, vol.274, pp.21491-21494, 1999.

J. L. Beaudeux, P. Giral, É. Bruckert, M. Foglietti, and J. Chapman, Métalloprotéases matricielles et athérosclérose. Perspectives thérapeutiques

, Ann. Biol. Clin, vol.61, pp.147-158, 2003.

M. Khoury, P. Giral, É. Bruckert, J. Chapman, J. L. Beaudeux et al., Une cible thérapeutique de l'athérosclérose? Sang Thromb. Vaiss, vol.18, pp.247-256, 2006.

A. David, Protéomique fonctionnelle des Métalloprotéases Matricielles (MMPs) dédié à la détection des formes acitves de MMPs dans des protéomes complexes, 2007.

M. Brkic, S. Balusu, C. Libert, and R. E. Vandenbroucke, Friends or Foes: Matrix Metalloproteinases and Their Multifaceted Roles in Neurodegenerative Diseases, Mediators Inflamm, 2015.

I. Bertini, Snapshots of the reaction mechanism of matrix metalloproteinases, Angew. Chemie -Int. Ed, vol.45, pp.7952-7955, 2006.

I. Sagi, J. Gaffney, . Matrix-metalloproteinase, and . Biology, , 2015.

Y. Itoh, Membrane-type matrix metalloproteinases: Their functions and regulations, Matrix Biol. 44, vol.46, pp.207-223, 2015.

H. Nagase, R. Visse, and G. Murphy, Structure and function of matrix metalloproteinases and TIMPs, Cardiovasc. Res, vol.69, pp.562-573, 2006.

B. Beekman, J. W. Drijfhout, H. K. Ronday, and J. M. Tekoppele, Fluorogenic MMP activity assay for plasma including MMPs complexed to ?2-macroglobulin, Ann. N. Y. Acad. Sci, vol.878, pp.150-158, 1999.

K. Maskos, Crystal structures of MMPs in complex with physiological and pharmacological inhibitors, Biochimie, vol.87, pp.249-263, 2005.

V. Arpino, M. Brock, and S. E. Gill, The role of TIMPs in regulation of Extracellular Matrix Proteolysis, Matrix Biol, vol.44, pp.247-254, 2015.

M. Khrestchatisky, Les Métalloprotéases de la matrice et leurs inhibiteurs , des modulateurs des interactions neuro-immunes et des processus physiopathologiques dans le système nerveux, J. Soc. Biol, vol.197, pp.133-144, 2003.

G. Gonzalez-avila, Matrix metalloproteinases participation in the metastatic process and their diagnostic and therapeutic applications in cancer

, Crit. Rev. Oncol. Hematol, vol.137, pp.57-83, 2019.

J. Hu, P. E. Van-den-steen, Q. A. Sang, and G. Opdenakker, Matrix metalloproteinase inhibitors as therapy for inflammatory and vascular diseases, Nat. Rev. Drug Discov, vol.6, pp.480-498, 2007.

L. Devel, Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity, Biochimie, vol.92, pp.1501-1508, 2010.

P. Jain, C. Saravanan, and S. K. Singh, Sulphonamides: Deserving class as MMP inhibitors?, Eur. J. Med. Chem, vol.60, pp.89-100, 2013.

L. Devel, Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S1' cavity, Biochimie, vol.92, pp.1501-1508, 2010.

C. Savi and . De, Selective non zinc binding inhibitors of MMP13, Bioorganic Med. Chem. Lett, vol.21, pp.4215-4219, 2011.

C. De-savi, Lead optimisation of selective non-zinc binding inhibitors of MMP13. Part 2, Bioorganic Med. Chem. Lett, vol.22, pp.271-277, 2012.

C. J. Malemud, Inhibition of MMPs and ADAM / ADAMTS, Biochem. Pharmacol, 2019.

X. X. Wang, M. S. Tan, J. T. Yu, and L. Tan, Matrix metalloproteinases and their multiple roles in Alzheimer's disease, Biomed Res Int, 2014.

S. Park, Gene Expression Profiling of Aging in Multiple Mouse Strains: Identification of Aging Biomarkers and Impact of Dietary Antioxidants, Aging Cell, vol.8, pp.484-495, 2009.

F. Safciuc, Advanced Glycation End Products, Oxidative Stress and Metalloproteinases are altered in the Cerebral Microvasculature during Aging

, Curr. Neurovasc. Res, vol.4, pp.228-234, 2007.

. Romero, Association of matrix metalloproteinases with MRI indices of brain ischemia and aging, Neurobiol. Aging, vol.31, pp.2128-2135, 2010.

Y. Liu, Matrix metalloproteinase-12 contributes to neuroinflammation in the aged brain, Neurobiol. Aging, vol.34, pp.1231-1239, 2013.

Y. Zhang, R. Thompson, H. Zhang, and H. Xu, APP processing in Alzheimer's disease, Mol. Brain, vol.4, pp.1-13, 2011.

M. Willem, ?-Secretase processing of APP inhibits neuronal activity in the hippocampus, Nature, vol.526, pp.443-447, 2015.

M. Ahmad, Cleavage of Amyloid-Precursor Protein (APP) by Membrane-Type Matrix Metalloproteinases, J. Biochem, vol.139, pp.517-526, 2006.

N. Philippi, Hippocampe et mémoire autobiographique: une étude en IRM volumétrique dans la maladie d'Alzheimer, Rev. Neurol, vol.168, p.24, 2012.

K. Baranger, MT5-MMP is a new pro-amyloidogenic proteinase that promotes amyloid pathology and cognitive decline in a transgenic mouse model of Alzheimer's disease, Cell. Mol. Life Sci, vol.73, pp.217-236, 2016.

K. Baranger, M. Khrestchatisky, S. Rivera, and . Mt5-mmp, just a new APP processing proteinase in Alzheimer's disease?, J. Neuroinflammation, vol.13, p.167, 2016.

K. Baranger, MT5-MMP Promotes Alzheimer's Pathogenesis in the Frontal Cortex of 5xFAD Mice and APP Trafficking in vitro, Front. Mol. Neurosci, vol.9, pp.1-17, 2017.

D. Pei, Identification and characterization of the fifth membrane-type matrix metalloproteinase MT5-MMP, J. Biol. Chem, vol.274, pp.8925-8932, 1999.

E. Llano, Identification and Characterization of Human MT5-MMP, a New Membrane-bound Activator of Progelatinase A Overexpressed in Brain Tumors 1, Cancer Res, vol.59, pp.2570-2576, 1999.

C. Helmer, L. Grasset, K. Pérès, and J. Dartigues, Évolution temporelle des démences : état des lieux en France et à l'international. Bull. épidémiologique Hebd, pp.467-473, 2016.

F. Eustache and B. Desgranges, Les conceptions de la mémoire déclarative d'Endel Tulving et leurs conséquences actuelles, Rev. Neuropsychol, vol.3, pp.94-103, 2011.

K. Maurer, S. Volk, and H. Gerbaldo, Alzheimer's disease, Lancet, vol.349, pp.1906-1909, 1997.

J. Jin and . Disease, JAMA, vol.313, p.1488, 2015.

B. L. Croisile and . Mini, Mental State, un incontournable de la neuropsychologie, Sci. Soc. Sante, vol.32, pp.71-77, 2014.

B. Baptiste, Un test rudimentaire mais pratique. Enquête sur le succès du Mini-Mental State Examination, Sci. Soc. Sante, vol.32, pp.43-70, 2014.

A. Cavalli, Multi-target-directed ligands to combat neurodegenerative diseases, J. Med. Chem, vol.51, pp.347-372, 2008.

R. P. Friedland and M. R. Chapman, The role of microbial amyloid in neurodegeneration, PLoS Pathog, vol.13, pp.1-12, 2017.

C. Reitz, Genetic diagnosis and prognosis of Alzheimer's disease: Challenges and opportunities, Expert Rev. Mol. Diagn, vol.15, pp.339-348, 2015.

T. Epperly, M. A. Dunay, and J. L. Boice, Alzheimer Disease: Pharmacologic and Nonpharmacologic Therapies for Cognitive and Functional Symptoms

, Fam. Physician, vol.95, pp.771-778, 2017.

Y. Madav, S. Wairkar, and B. Prabhakar, Recent therapeutic strategies targeting beta amyloid and tauopathies in Alzheimer's disease, Brain Res. Bull, vol.146, pp.171-184, 2019.

S. Y. Hung and W. M. Fu, Drug candidates in clinical trials for Alzheimer's disease, J. Biomed. Sci, vol.24, pp.1-12, 2017.

S. Claeysen, J. Bockaert, and P. Giannoni, Serotonin: A New Hope in Alzheimer's Disease?, ACS Chem. Neurosci, vol.6, pp.940-943, 2015.

A. Zlomuzica, Neuronal histamine and cognitive symptoms in Alzheimer's disease, Neuropharmacology, vol.106, pp.135-145, 2016.

E. Popugaeva, E. Pchitskaya, and I. Bezprozvanny, Dysregulation of neuronal calcium homeostasis in Alzheimer's disease -a therapeutic opportunity?, Biochem. Biophys. Res. Commun, vol.483, pp.998-1004, 2017.

B. T. Golde, S. T. Dekosky, and D. Galasko, Alzheimer's disease: The right drug, the right time, vol.362, pp.1250-1252, 2018.

O. Preische and S. A. Schultz, Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease, Nat. Med, vol.25, pp.277-283, 2019.

D. Rognan, Méthodes de criblage in silico de chimiothèques, Tech. l'Ingénieur, vol.33, 2014.

. Iupac, Compendium of Chemical Terminology

, Blackwell Sci. Publ. Oxford, vol.1670, 2014.

C. G. Wermuth, C. R. Ganellin, P. Lindberg, and L. A. Mitscher, Glossary of Terms Used in Medicinal Chemistry, Pure Appl. Chem, vol.70, pp.1129-1143, 1998.

S. Kirkiacharian, Chimie médicinale -Structure et activité du médicament, Tech. l'Ingénieur, vol.33, 2007.

T. Engel and . Gasteiger, J. Applied Chemoinformatics : Achievements and Future Opportunities, 2018.

T. C. França, Homology modeling: An important tool for the drug discovery

, J. Biomol. Struct. Dyn, vol.33, pp.1780-1793, 2015.

M. Murphy, Gene Help: Integrated Access to Genes of Genomes in the Reference Sequence Collection, 2006.

D. R. Zerbino, Nucleic Acids Res, vol.46, pp.754-761, 2018.

H. M. Berman, The Protein Data Bank, Nucleic Acids Res, vol.28, pp.235-242, 2000.

R. Apweiler, UniProt: The universal protein knowledgebase, Nucleic Acids Res, vol.32, pp.115-119, 2006.

A. Fabregat, The Reactome Pathway Knowledgebase, Nucleic Acids Res, vol.46, pp.649-655, 2018.

D. N. Slenter, WikiPathways: A multifaceted pathway database bridging metabolomics to other omics research, Nucleic Acids Res, vol.46, pp.661-667, 2018.

E. G. Cerami, Pathway Commons, a web resource for biological pathway data, Nucleic Acids Res, vol.39, pp.685-690, 2011.

M. Kanehisa, Y. Sato, M. Furumichi, K. Morishima, and M. Tanabe, New approach for understanding genome variations in KEGG, Nucleic Acids Res, pp.1-6, 2018.

D. Carvalho-silva, Open Targets Platform: new developments and updates two years on, Nucleic Acids Res. 1, p.10, 2018.

J. Macarthur, The new NHGRI-EBI Catalog of published genome-wide association studies (GWAS Catalog), Nucleic Acids Res, vol.45, pp.896-901, 2017.

J. Barretina, The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity, Nature, vol.483, pp.603-607, 2012.

J. S. Amberger, C. A. Bocchini, F. Schiettecatte, A. F. Scott, A. O. Hamosh et al., Online Mendelian Inheritance in Man (OMIM®), an Online catalog of human genes and genetic disorders, Nucleic Acids Res, vol.43, pp.789-798, 2015.

T. Tse, A. B. Zarin, and D. A. Trialists, Intent to Share Individual Participant Data as Disclosed at ClinicalTrials.gov, JAMA -J. Am. Med. Assoc, vol.319, pp.406-408, 2018.

A. Tsherniak, Defining a Cancer Dependency Map, Cell, vol.170, pp.564-576, 2017.

B. A. Aksoy, CTD2 Dashboard: a searchable web interface to connect validated results from the Cancer Target Discovery and Development Network, Database, vol.2017, pp.1-10, 2017.

A. Gaulton, ChEMBL: A large-scale bioactivity database for drug discovery, Nucleic Acids Res, vol.40, pp.1100-1107, 2012.

S. Kim, PubChem substance and compound databases, Nucleic Acids Res, vol.44, pp.1202-1213, 2015.

J. L. Little, A. J. Williams, A. Pshenichnov, and V. Tkachenko, Identification of 'known unknowns' utilizing accurate mass data and chemspider, J. Am. Soc. Mass Spectrom, vol.23, pp.179-185, 2012.

T. Sterling and J. J. Irwin, ZINC 15 -Ligand Discovery for Everyone, J. Chem. Inf. Model, vol.55, pp.2324-2337, 2015.

D. S. Wishart, DrugBank 5.0: A major update to the DrugBank database for 2018, Nucleic Acids Res, vol.46, pp.1074-1082, 2018.

A. Lagunin, A. Stepanchikova, D. Filimonov, and V. Poroikov, PASS : prediction of activity spectra for biologically active substances, Bioinforma. Appl. Note, vol.16, pp.747-748, 2000.

A. Nguyen and A. Van-nguyen, The Process of Structure-Based Drug Design, Chem. Biol, vol.10, pp.787-797, 2003.

T. L. Blundell, Structure-based drug design, Nature, vol.384, pp.23-26, 1996.

B. L. Vallee and D. S. Auld, Active-site zinc ligands and activated H2O of zinc enzymes, Proc. Natl. Acad. Sci, vol.87, pp.220-224, 1990.

B. Pirard, Insight into the structural determinants for selective inhibition of matrix metalloproteinases, Drug Discov. Today, vol.12, pp.640-646, 2007.

A. Tochowicz, Crystal Structures of MMP-9 Complexes with Five Inhibitors: Contribution of the Flexible Arg424 Side-chain to Selectivity, J. Mol. Biol, vol.371, pp.989-1006, 2007.

B. Fabre, A. Ramos, and B. De-pascual-teresa, Targeting matrix metalloproteinases: Exploring the dynamics of the S1? pocket in the design of selective, small molecule inhibitors, J. Med. Chem, vol.57, pp.10205-10219, 2014.

K. Kawai and N. Nagata, Metal-ligand interactions: An analysis of zinc binding groups using the Protein Data Bank, Eur. J. Med. Chem, vol.51, pp.271-276, 2012.

D. Leung, G. Abbenante, and D. P. Fairlie, Protease inhibitors: Current status and future prospects, J. Med. Chem, vol.43, pp.305-341, 2000.

C. Kapoor, Seesaw of matrix metalloproteinases (MMPs), J. Cancer Res. Ther, vol.12, pp.28-35, 2016.